Table 4:
Outcome | 1. Treated Continuously | 2. Discontinued Treatment Early | 3. Treated Intermittently | P-value 1 vs 2 | P-value 1 vs 3 | P-value 2 vs 3 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LS Mean | Lower 95% CI | Upper 95% CI | LS Mean | Lower 95% CI | Upper 95% CI | LS Mean | Lower 95% CL | Upper 95% CL | ||||
VALS | 68.6 | 65.8 | 71.4 | 73.2 | 67.8 | 78.6 | 67.4 | 63.4 | 71.5 | 0.14 | 0.65 | 0.10 |
Change from baseline in VALS | 18.6 | 15.6 | 21.5 | 23.4 | 17.7 | 29.1 | 17.2 | 13.0 | 21.5 | 0.14 | 0.61 | 0.09 |
CST | 300 | 285 | 315 | 257 | 227 | 287 | 303 | 281 | 325 | 0.01 | 0.81 | 0.02 |
Change from baseline in CST | −397 | −415 | −380 | −443 | −477 | −409 | −394 | −419 | −369 | 0.02 | 0.81 | 0.02 |
Abbreviations: LS=Least Square; CL=Confidence Limits; VALS-Visual Acuity Letter Score; CST=Central Subfield Thickness.